Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Why support-platform strategy may become a differentiator in schizophrenia treatment markets See why Teva Pharmaceutical Industries Ltd.’s support-platform strategy could reshape schizophrenia treatment markets and competitive positioning. Read more. bySoujanya RaviApril 18, 2026